|
⚲
|
| Keyboard |
| Kucharchuk Andrew Albert
✚
|
|
|---|---|
| CIK # | 0001654127 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001654127] | |
| 4 | [0001654127] | |
| SC 13D | [0001654127] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Kucharchuk Andrew Albert | Oncbiomune Pharmaceuticals Inc | [2016-02-04] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2026-01-07 | Grant | 1,162,099 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2025-05-30 | Grant | 152,500 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2024-10-01 | Grant | 500,000 | $0.00 | |
|
Theralink Technologies Inc OBMP
Series D-2 Convertible Preferred Stock · derivative
|
2020-06-05 | Grant | 241 | ||
|
Theralink Technologies Inc OBMP
Shares of Common Stock
|
2020-05-07 | Grant | 283,334 | $0.06 | 17,000 |
|
Theralink Technologies Inc OBMP
Option (right to buy) · derivative
|
2018-05-09 | Grant | 3,000,000 | ||
|
Theralink Technologies Inc OBMP
Emplyee Stock Option (right to buy) · derivative
|
2017-03-10 | Grant | 2,000,000 | ||
|
Theralink Technologies Inc OBMP
Common stock
|
2015-09-02 | Grant | 5,000,000 |